In vivo magnetic resonance spectroscopy by transverse relaxation encoding with narrowband decoupling.
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
27 07 2023
27 07 2023
Historique:
received:
07
04
2023
accepted:
25
07
2023
medline:
31
7
2023
pubmed:
28
7
2023
entrez:
27
7
2023
Statut:
epublish
Résumé
Cell pathology in neuropsychiatric disorders has mainly been accessible by analyzing postmortem tissue samples. Although molecular transverse relaxation informs local cellular microenvironment via molecule-environment interactions, precise determination of the transverse relaxation times of molecules with scalar couplings (J), such as glutamate and glutamine, has been difficult using in vivo magnetic resonance spectroscopy (MRS) technologies, whose approach to measuring transverse relaxation has not changed for decades. We introduce an in vivo MRS technique that utilizes frequency-selective editing pulses to achieve homonuclear decoupled chemical shift encoding in each column of the acquired two-dimensional dataset, freeing up the entire row dimension for transverse relaxation encoding with J-refocusing. This results in increased spectral resolution, minimized background signals, and markedly broadened dynamic range for transverse relaxation encoding. The in vivo within-subject coefficients of variation for the transverse relaxation times of glutamate and glutamine, measured using the proposed method in the human brain at 7 T, were found to be approximately 4%. Since glutamate predominantly resides in glutamatergic neurons and glutamine in glia in the brain, this noninvasive technique provides a way to probe cellular pathophysiology in neuropsychiatric disorders for characterizing disease progression and monitoring treatment response in a cell type-specific manner in vivo.
Identifiants
pubmed: 37500714
doi: 10.1038/s41598-023-39375-0
pii: 10.1038/s41598-023-39375-0
pmc: PMC10374641
doi:
Substances chimiques
Glutamine
0RH81L854J
Glutamic Acid
3KX376GY7L
Banques de données
ClinicalTrials.gov
['NCT01266577']
Types de publication
Journal Article
Research Support, N.I.H., Intramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
12211Subventions
Organisme : Intramural NIH HHS
ID : ZIA MH002803
Pays : United States
Informations de copyright
© 2023. This is a U.S. Government work and not under copyright protection in the US; foreign copyright protection may apply.
Références
NMR Biomed. 2023 Jul;36(7):e4910
pubmed: 36681860
Magn Reson Med. 2019 Feb;81(2):746-758
pubmed: 30329186
Clin Psychopharmacol Neurosci. 2017 Feb 28;15(1):1-8
pubmed: 28138104
Magn Reson Med. 2016 Sep;76(3):725-32
pubmed: 26361892
Magn Reson Med. 1995 Sep;34(3):331-7
pubmed: 7500871
MAGMA. 2019 Apr;32(2):237-246
pubmed: 30467687
NMR Biomed. 2021 May;34(5):e4197
pubmed: 31782845
J Biomed Res. 2019 Oct 31;34(4):260-270
pubmed: 32594024
Magn Reson Med. 2001 Jul;46(1):58-67
pubmed: 11443711
CNS Neurol Disord Drug Targets. 2007 Jun;6(3):219-33
pubmed: 17511618
Magn Reson Med. 2004 Mar;51(3):435-40
pubmed: 15004781
Magn Reson Imaging. 1995;13(6):853-69
pubmed: 8544657
NMR Biomed. 2012 Apr;25(4):523-9
pubmed: 21845738
Med Phys. 2017 Aug;44(8):4169-4178
pubmed: 28548302
Biomolecules. 2020 Oct 09;10(10):
pubmed: 33050144
Prog Neuropsychopharmacol Biol Psychiatry. 2019 Apr 20;91:94-102
pubmed: 30125624
Trends Cancer. 2017 Mar;3(3):169-180
pubmed: 28393116
Magn Reson Med. 2018 May;79(5):2491-2499
pubmed: 28940581
Magn Reson Med. 2021 Nov;86(5):2384-2401
pubmed: 34268821
Psychiatry Res. 2013 Aug 30;213(2):142-53
pubmed: 23769421
NMR Biomed. 2012 Feb;25(2):332-9
pubmed: 21796710
Magn Reson Med. 2005 Oct;54(4):761-8
pubmed: 16161114
Magn Reson Med. 1991 Jan;17(1):82-94
pubmed: 1648655
J Magn Reson. 2020 May;314:106732
pubmed: 32361510
Magn Reson Med. 2020 Nov;84(5):2327-2337
pubmed: 32430928
NMR Biomed. 2006 Apr;19(2):255-63
pubmed: 16541464
Magn Reson Med. 1994 Aug;32(2):251-7
pubmed: 7968450
NMR Biomed. 2013 Dec;26(12):1630-46
pubmed: 24123328
Magn Reson Imaging. 1999 Jan;17(1):141-50
pubmed: 9888407
Biomolecules. 2015 Nov 11;5(4):3112-41
pubmed: 26569330
Proc Natl Acad Sci U S A. 1997 Mar 18;94(6):2699-704
pubmed: 9122259
NMR Biomed. 2022 Dec;35(12):e4801
pubmed: 35833462
Neurochem Res. 2015 Dec;40(12):2570-82
pubmed: 25428182
J Magn Reson B. 1996 Nov;113(2):103-18
pubmed: 8948135
Sci Rep. 2020 Nov 24;10(1):20435
pubmed: 33235296
Schizophr Res. 2021 Jun;232:42-44
pubmed: 34015554
J Magn Reson Imaging. 2013 Jun;37(6):1445-50
pubmed: 23172656
NMR Biomed. 2010 Nov;23(9):1044-52
pubmed: 20963800
Proc Natl Acad Sci U S A. 1999 Jul 6;96(14):8235-40
pubmed: 10393978
Magn Reson Med. 2014 Feb;71(2):458-68
pubmed: 23475809
AJNR Am J Neuroradiol. 2022 Jan;43(1):11-18
pubmed: 34737183
Sci Rep. 2015 Feb 11;5:8380
pubmed: 25670024
Magn Reson Med. 2017 Dec;78(6):2072-2081
pubmed: 28164364
NMR Biomed. 2013 Oct;26(10):1291-8
pubmed: 23564618
J Magn Reson. 2022 Aug;341:107257
pubmed: 35752065
Front Mol Neurosci. 2018 Feb 27;11:56
pubmed: 29535607
Magn Reson Med. 2018 Aug;80(2):452-461
pubmed: 29344979
Neurobiol Aging. 2013 Apr;34(4):1265-76
pubmed: 23116877
Magn Reson Med. 1989 Jul;11(1):47-63
pubmed: 2747516
Magn Reson Med. 2010 Jan;63(1):1-8
pubmed: 19918902
Psychiatry Res. 2007 Apr 15;154(3):267-73
pubmed: 17346948